Explore the words cloud of the MITrep project. It provides you a very rough idea of what is the project "MITrep" about.
The following table provides information about the project.
|Coordinator Country||France [FR]|
|Total cost||71˙429 €|
|EC max contribution||50˙000 € (70%)|
1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
|Duration (year-month-day)||from 2018-12-01 to 2019-05-31|
Take a look of project's partnership.
|1||CMI NOV||FR (MONISTROL SUR LOIRE)||coordinator||50˙000.00|
Mitral valve insufficiency is a heart condition, where blood is abnormally leaking out of the mitral valve. This condition mainly afflicts the elderly patients: - 80% of patients aged 80 show moderate symptoms (chronic fatigue, shortness of breath, palpitations, racing heart rate) - 10% of patients above 75 with severe symptoms are at risk of a sudden death (stroke) within 5 years. - Prevalence will double by 2030. Mitral insufficiency is treated with open heart surgery (300,000 operations/year in the EU and the USA) followed by intensive care. But this operation is unbearable for fragile patients. Half of the patients above 75 are tagged inoperable because of their age. Less invasive repair surgeries have been tested (annuloplasty by transfemoral surgery) but lack efficiency and safety and require highly skilled surgeons (not available in each hospital). In this context, the company CMI’nov has developed MITrep, the first patented mini-invasive surgical device that automatically goes to the mitral valve with no trial and error to affix a leak-preventing ring on the valve. It uses the transapical approach. Once the ring is anchored, the mitral valve returns to normal activity. No heavy post-surgery effects are expected. No intensive care required.
MITrep can be used by any surgeons : no need to be a mitral valve specialist. It will allow to halve the operation time (from 5 hours to less than 2 hours), reduce hospitalization time to 3 days (vs 5-8 days with 2 days in ICU) and cost about three times less than open heart surgery (30k€ vs 80k€). It means a dramatic cost reduction for healthcare systems and a real improvement of the care of the elderly patient.
This project holds the ambition to build a new gold standard in valvuloplasty worldwide, starting with mitral repair and replicable to aortic and tricuspid valve repair. It is also a value driver for CMI’nov. The Phase 1 project will validate the feasibility of MITrep before scale-up and deployment.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MITREP" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "MITREP" are provided by the European Opendata Portal: CORDIS opendata.
NATURE FRIENDLY WATER HYDRAULIC STEERING SYSTEMRead More
First in the world ecological and sustainable cream for wound care, based on microalgaprasinococcus capsulatusRead More
Mobile technology that brings personalized audio into your lifeRead More